The Implication of Serum Autoantibodies in Prognosis of Canine Mammary Tumors

• Published in: Animals (Basel) Vol. 12; no. 18; p. 2463
• Main Authors: Yuan, Stephen Hsien-Chi, Chang, Shih-Chieh, Chou, Pei-Yi, Yang, Youngsen, Liu, Hao-Ping
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.09.2022; MDPI
• Subjects: Antigens; autoantibodies; autoantibody; Biomarkers; blood serum; Cancer; canine; Dogs; Enzymes; females; hyaluronic acid; insulin-like growth factor binding proteins; mammary neoplasms (animal); mammary tumor; Mastectomy; Medical prognosis; metastasis; Peptides; Pets; prediction; prognosis; Proteins; proteoglycans; serum; surgery; survival; thymidylate synthase; Tumors; United States > US; Taiwan; canine; mammary tumor; autoantibody; serum; prognosis; survival

Canine mammary tumor (CMT) is the most prevalent neoplasm in female dogs. Tumor recurrence and metastasis occur in malignant CMT (MMT) dogs after surgery. Identification of serum prognostic biomarkers holds the potential to facilitate prediction of disease outcomes. We have identified CMT-associated...